All journal publications
Filters: author is Bergstrom [Clear All Filters]
- 2008
Pharmacokinetics of P-glycoprotein inhibition in the rat blood-brain barrier,
J Pharm Sci, vol. 97, no. 12, pp. 5386-400. DOI
Pharmacokinetics of P-glycoprotein inhibition in the rat blood-brain barrier,
J Pharm Sci, vol. 97, no. 12, pp. 5386-400. DOI
Pharmacokinetics of P-glycoprotein inhibition in the rat blood-brain barrier,
J Pharm Sci, vol. 97, no. 12, pp. 5386-400. DOI
- 2007
PET-evaluated transport of [11C]hydroxyurea across the rat blood-brain barrier--lack of influence of cyclosporin and probenecid,
Drug Metab Lett, vol. 1, no. 3, pp. 189-94.
PET-evaluated transport of [11C]hydroxyurea across the rat blood-brain barrier--lack of influence of cyclosporin and probenecid,
Drug Metab Lett, vol. 1, no. 3, pp. 189-94.
PET-evaluated transport of [11C]hydroxyurea across the rat blood-brain barrier--lack of influence of cyclosporin and probenecid,
Drug Metab Lett, vol. 1, no. 3, pp. 189-94.
- 2006
Duration and degree of cyclosporin induced P-glycoprotein inhibition in the rat blood-brain barrier can be studied with PET,
Neuroimage, vol. 32, no. 3, pp. 1134-41. DOI
Duration and degree of cyclosporin induced P-glycoprotein inhibition in the rat blood-brain barrier can be studied with PET,
Neuroimage, vol. 32, no. 3, pp. 1134-41. DOI
Duration and degree of cyclosporin induced P-glycoprotein inhibition in the rat blood-brain barrier can be studied with PET,
Neuroimage, vol. 32, no. 3, pp. 1134-41. DOI
Predicting brain concentrations of drug using positron emission tomography and venous input: modeling of arterial-venous concentration differences,
Eur J Clin Pharmacol, vol. 62, no. 10, pp. 839-48. DOI
Predicting brain concentrations of drug using positron emission tomography and venous input: modeling of arterial-venous concentration differences,
Eur J Clin Pharmacol, vol. 62, no. 10, pp. 839-48. DOI
Predicting brain concentrations of drug using positron emission tomography and venous input: modeling of arterial-venous concentration differences,
Eur J Clin Pharmacol, vol. 62, no. 10, pp. 839-48. DOI
Blood-brain barrier penetration of zolmitriptan--modelling of positron emission tomography data,
J Pharmacokinet Pharmacodyn, vol. 33, no. 1, pp. 75-91. DOI
Blood-brain barrier penetration of zolmitriptan--modelling of positron emission tomography data,
J Pharmacokinet Pharmacodyn, vol. 33, no. 1, pp. 75-91. DOI
Blood-brain barrier penetration of zolmitriptan--modelling of positron emission tomography data,
J Pharmacokinet Pharmacodyn, vol. 33, no. 1, pp. 75-91. DOI


